Diagnosis

Quantitative Sensory Testing in 2026: Measuring Nerve Function Thresholds to Differentiate Small vs Large Fiber Neuropathy

When "normal" nerve tests aren't enough

Erin was told three times her EMG looked normal, yet her feet still burned at night and even the sheets hurt. She was sent home with orthotics and antidepressants. Nothing changed. Then a neurologist ordered a quantitative sensory test, QST, to see how her nerves actually sensed heat, cold, and pressure. That’s when the difference appeared: her small fibers were failing.

The pattern matters. Nerves that manage touch, vibration, and reflexes are large fibers. Those carrying pain and temperature are small fibers. Damage in each group behaves, feels, and responds differently. QST is one of the few tools that can measure that difference instead of leaving it to guesswork.

What quantitative sensory testing really measures

Nerve testing isn’t just shocks and needles. QST focuses on thresholds. Sitting in a controlled room, the patient feels subtle, gradually changing temperatures or pressures. The device notes the exact moment warmth, cold, pain, or vibration registers. Data are compared with normal values for age and sex.

Losing vibration sensitivity indicates large fiber dysfunction. When heat or cold detection fades but vibration remains normal, that points to small fiber loss. QST captures function in real time, unlike a skin biopsy that shows only nerve density. It’s about behavior, not structure.

The MedlinePlus database, which added new test listings in 2025, now includes QST among its standard neurologic diagnostics (MedlinePlus). That shift marks QST’s move from a research niche to an accepted clinical tool.

Why fine-tuned nerve measurements matter in 2026

In just a year, our understanding of sensory nerves has deepened. ScienceDaily reported new findings on delicate fibers that trigger mechanical itch and pain (ScienceDaily). These are the same networks that wear down early in diabetes and autoimmune neuropathies. And now, ordinary clinics, not just labs, can measure them directly.

Knowing which fibers are damaged drives treatment choices. Small fiber neuropathy often shows up years before diabetes. It can also reveal autoimmune, metabolic, or toxic causes invisible to standard conduction tests. Large fiber loss, in contrast, tends to signal B12 deficiency, nerve compression, or long-term diabetes. The approaches differ, and detecting the right one matters.

It’s like cardiology evolving from pulse counts to mapping how exercise rewires cardiac nerves, as this year’s data showed. Nerves adapt, and we can measure it (ScienceDaily). The same principle now applies to sensory testing: precision changes what can actually be fixed.

When to ask for QST and what to expect

If your EMG looks fine but pain, tingling, or temperature issues persist, bring up QST with your neurologist. It’s especially useful if skin biopsy isn’t an option. Noninvasive, repeatable, and able to track change over time.

During testing:

  • You sit in a temperature-controlled room and rest for about 15-20 minutes.
  • Probes are placed on skin, usually feet or hands.
  • Heat, cold, or vibration rises gradually.
  • You press a button when sensation starts and again when it turns uncomfortable.

The output is a sensory profile, different frequencies, different modalities. Your doctor can see if symptoms follow a length-dependent pattern (worse in feet, better in thighs) or a patchier distribution hinting at immune or toxic causes. That guides next steps, labs, medication choice, or immune therapy.

No single test decides a neuropathy diagnosis. QST adds context to blood work, biopsy, and exam results. Still, when those conflict, this one often clarifies the picture.

The bigger picture: nerves built on compromise

The human nervous system wasn’t engineered for long modern lifespans. As ScienceDaily noted, much of our body’s design is compromise, the same traits that make us sensitive also make us fragile (ScienceDaily). Tiny fibers run through tissue with minimal protection, marvelous yet breakable. QST gives a way to spot those early cracks before biopsy confirms loss.

Erin’s follow-up QST a year later showed her small fiber thresholds stabilizing once her blood sugar improved and a neurotoxic drug was stopped. That happened because someone measured what was actually wrong, finally.

Sources

Neuro AI
Neuropathy Specialist
Hello! I can help with your neuropathy questions. Ask me about symptoms, causes, treatments, or daily management.